COVID-19 Impact on Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Insights, Forecast to 2026
SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry.
Based on our recent survey, we have several different scenarios about the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors industry.
Based on our recent survey, we have several different scenarios about the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market.
The following manufacturers are covered in this report:
- Eli Lilly
- Janssen Pharmaceuticals
- Astellas
- Boehringer Ingelheim
- AstraZeneca
- Bristol Myers Squibb
- Kotobuki Pharmaceutical
- ...
- Invokana (Canagliflozin)
- Jardiance (Empagliflozin)
- Farxiga/Forxiga (Dapagliflozin)
- Suglat (Ipragliflozin)
- Hospital
- Medical Research Institute
- Other
1 STUDY COVERAGE
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type
1.4.2 Invokana (Canagliflozin)
1.4.3 Jardiance (Empagliflozin)
1.4.4 Farxiga/Forxiga (Dapagliflozin)
1.4.5 Suglat (Ipragliflozin)
1.5 Market by Application
1.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Impact
1.6.1 How the Covid-19 is Affecting the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry
1.6.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Estimates and Forecasts
2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2015-2026
2.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2015-2026
2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region: 2020 Versus 2026
2.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers
3.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers
3.2.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2019
3.2.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturers
3.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020)
4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2015-2020)
4.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020)
5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2015-2020)
5.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2015-2020)
5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
6.1.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
6.1.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
6.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
7 EUROPE
7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Region
8.1.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region
8.1.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
9.1.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
9.1.2 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
9.3 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
10.1.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
10.1.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description, Business Overview and Total Revenue
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.1.5 Eli Lilly Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Corporation Information
11.2.2 Janssen Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Astellas
11.3.1 Astellas Corporation Information
11.3.2 Astellas Description, Business Overview and Total Revenue
11.3.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.3.5 Astellas Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description, Business Overview and Total Revenue
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Corporation Information
11.6.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.6.5 Bristol Myers Squibb Recent Development
11.7 Kotobuki Pharmaceutical
11.7.1 Kotobuki Pharmaceutical Corporation Information
11.7.2 Kotobuki Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 Kotobuki Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.7.5 Kotobuki Pharmaceutical Recent Development
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description, Business Overview and Total Revenue
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.1.5 Eli Lilly Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Projections by Region
12.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type
1.4.2 Invokana (Canagliflozin)
1.4.3 Jardiance (Empagliflozin)
1.4.4 Farxiga/Forxiga (Dapagliflozin)
1.4.5 Suglat (Ipragliflozin)
1.5 Market by Application
1.5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Research Institute
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Impact
1.6.1 How the Covid-19 is Affecting the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry
1.6.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Estimates and Forecasts
2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2015-2026
2.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2015-2026
2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region: 2020 Versus 2026
2.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL SODIUM/GLUCOSE COTRANSPORTER 2 (SGLT 2) INHIBITORS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers
3.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers
3.2.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2019
3.2.5 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturers
3.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020)
4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2015-2020)
4.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020)
5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2015-2020)
5.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2015-2020)
5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
6.1.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
6.1.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
6.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
7 EUROPE
7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
7.1.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
7.1.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Region
8.1.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region
8.1.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
9.1.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
9.1.2 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
9.3 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Country
10.1.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country
10.1.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description, Business Overview and Total Revenue
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.1.5 Eli Lilly Recent Development
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Corporation Information
11.2.2 Janssen Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.2.5 Janssen Pharmaceuticals Recent Development
11.3 Astellas
11.3.1 Astellas Corporation Information
11.3.2 Astellas Description, Business Overview and Total Revenue
11.3.3 Astellas Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.3.5 Astellas Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Description, Business Overview and Total Revenue
11.5.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.5.5 AstraZeneca Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Corporation Information
11.6.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
11.6.3 Bristol Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.6.5 Bristol Myers Squibb Recent Development
11.7 Kotobuki Pharmaceutical
11.7.1 Kotobuki Pharmaceutical Corporation Information
11.7.2 Kotobuki Pharmaceutical Description, Business Overview and Total Revenue
11.7.3 Kotobuki Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.7.5 Kotobuki Pharmaceutical Recent Development
11.1 Eli Lilly
11.1.1 Eli Lilly Corporation Information
11.1.2 Eli Lilly Description, Business Overview and Total Revenue
11.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
11.1.5 Eli Lilly Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Projections by Region
12.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segments
Table 2. Ranking of Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Invokana (Canagliflozin)
Table 5. Major Manufacturers of Jardiance (Empagliflozin)
Table 6. Major Manufacturers of Farxiga/Forxiga (Dapagliflozin)
Table 7. Major Manufacturers of Suglat (Ipragliflozin)
Table 8. COVID-19 Impact Global Market: (Four Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players to Combat Covid-19 Impact
Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application 2020-2026 (Kg)
Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions 2015-2020 (Kg)
Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions (2015-2020)
Table 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2015-2020) (Kg)
Table 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers (2015-2020)
Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2019)
Table 22. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2015-2020) (USD/Kg)
Table 25. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
Table 27. Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2015-2020)
Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2015-2020)
Table 33. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 35. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2015-2020)
Table 36. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 37. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 38. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 41. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 42. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 43. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 44. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 45. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 46. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 48. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 49. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 50. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2015-2020) (Kg)
Table 53. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 57. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 59. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 60. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 61. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 64. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 65. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 66. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 67. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 69. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 73. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 75. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 76. Eli Lilly Corporation Information
Table 77. Eli Lilly Description and Major Businesses
Table 78. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Eli Lilly Product
Table 80. Eli Lilly Recent Development
Table 81. Janssen Pharmaceuticals Corporation Information
Table 82. Janssen Pharmaceuticals Description and Major Businesses
Table 83. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Janssen Pharmaceuticals Product
Table 85. Janssen Pharmaceuticals Recent Development
Table 86. Astellas Corporation Information
Table 87. Astellas Description and Major Businesses
Table 88. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Astellas Product
Table 90. Astellas Recent Development
Table 91. Boehringer Ingelheim Corporation Information
Table 92. Boehringer Ingelheim Description and Major Businesses
Table 93. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Boehringer Ingelheim Product
Table 95. Boehringer Ingelheim Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Bristol Myers Squibb Corporation Information
Table 102. Bristol Myers Squibb Description and Major Businesses
Table 103. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Bristol Myers Squibb Product
Table 105. Bristol Myers Squibb Recent Development
Table 106. Kotobuki Pharmaceutical Corporation Information
Table 107. Kotobuki Pharmaceutical Description and Major Businesses
Table 108. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Kotobuki Pharmaceutical Product
Table 110. Kotobuki Pharmaceutical Recent Development
Table 111. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions (2021-2026) (Kg)
Table 112. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 116. North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 118. Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2021-2026) (Kg)
Table 120. Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 122. Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 124. Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players
Table 129. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers List
Table 130. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segments
Table 2. Ranking of Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Invokana (Canagliflozin)
Table 5. Major Manufacturers of Jardiance (Empagliflozin)
Table 6. Major Manufacturers of Farxiga/Forxiga (Dapagliflozin)
Table 7. Major Manufacturers of Suglat (Ipragliflozin)
Table 8. COVID-19 Impact Global Market: (Four Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players to Combat Covid-19 Impact
Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application 2020-2026 (Kg)
Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions 2015-2020 (Kg)
Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions (2015-2020)
Table 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2015-2020) (Kg)
Table 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers (2015-2020)
Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2019)
Table 22. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2015-2020) (USD/Kg)
Table 25. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
Table 27. Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2015-2020)
Table 31. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2015-2020)
Table 33. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 35. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2015-2020)
Table 36. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 37. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 38. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 41. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 42. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 43. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 44. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 45. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 46. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 48. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 49. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 50. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 51. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2015-2020) (Kg)
Table 53. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 57. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 59. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 60. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 61. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 64. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 65. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 66. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 67. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2015-2020) (Kg)
Table 69. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2015-2020) (Kg)
Table 73. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2015-2020) (Kg)
Table 75. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Table 76. Eli Lilly Corporation Information
Table 77. Eli Lilly Description and Major Businesses
Table 78. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Eli Lilly Product
Table 80. Eli Lilly Recent Development
Table 81. Janssen Pharmaceuticals Corporation Information
Table 82. Janssen Pharmaceuticals Description and Major Businesses
Table 83. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Janssen Pharmaceuticals Product
Table 85. Janssen Pharmaceuticals Recent Development
Table 86. Astellas Corporation Information
Table 87. Astellas Description and Major Businesses
Table 88. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Astellas Product
Table 90. Astellas Recent Development
Table 91. Boehringer Ingelheim Corporation Information
Table 92. Boehringer Ingelheim Description and Major Businesses
Table 93. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Boehringer Ingelheim Product
Table 95. Boehringer Ingelheim Recent Development
Table 96. AstraZeneca Corporation Information
Table 97. AstraZeneca Description and Major Businesses
Table 98. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. AstraZeneca Product
Table 100. AstraZeneca Recent Development
Table 101. Bristol Myers Squibb Corporation Information
Table 102. Bristol Myers Squibb Description and Major Businesses
Table 103. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Bristol Myers Squibb Product
Table 105. Bristol Myers Squibb Recent Development
Table 106. Kotobuki Pharmaceutical Corporation Information
Table 107. Kotobuki Pharmaceutical Description and Major Businesses
Table 108. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Kotobuki Pharmaceutical Product
Table 110. Kotobuki Pharmaceutical Recent Development
Table 111. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions (2021-2026) (Kg)
Table 112. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 116. North America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 118. Europe: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2021-2026) (Kg)
Table 120. Asia Pacific: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 122. Latin America: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Country (2021-2026) (Kg)
Table 124. Middle East and Africa: Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players
Table 129. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers List
Table 130. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
Figure 2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Invokana (Canagliflozin) Product Picture
Figure 4. Jardiance (Empagliflozin) Product Picture
Figure 5. Farxiga/Forxiga (Dapagliflozin) Product Picture
Figure 6. Suglat (Ipragliflozin) Product Picture
Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Medical Research Institute
Figure 10. Other
Figure 11. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered
Figure 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size 2015-2026 (US$ Million)
Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2015-2026 (Kg)
Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2015-2020)
Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2019
Figure 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2015-2020)
Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2019
Figure 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2019
Figure 21. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Figure 23. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2019
Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2015-2020)
Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type in 2019
Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Price Range (2015-2020)
Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2019
Figure 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2015-2020)
Figure 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2019
Figure 31. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 34. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 35. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 40. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 41. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 44. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 45. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 56. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 57. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2019
Figure 60. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2019
Figure 61. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 84. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 85. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 88. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 89. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 96. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 97. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 101. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 108. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 109. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Kotobuki Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 121. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 123. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 125. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
Figure 2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Invokana (Canagliflozin) Product Picture
Figure 4. Jardiance (Empagliflozin) Product Picture
Figure 5. Farxiga/Forxiga (Dapagliflozin) Product Picture
Figure 6. Suglat (Ipragliflozin) Product Picture
Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Medical Research Institute
Figure 10. Other
Figure 11. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered
Figure 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size 2015-2026 (US$ Million)
Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2015-2026 (Kg)
Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2015-2020)
Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2019
Figure 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2015-2020)
Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2019
Figure 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2019
Figure 21. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2015-2020)
Figure 23. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2019
Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2015-2020)
Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type in 2019
Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Price Range (2015-2020)
Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2015-2020)
Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2019
Figure 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2015-2020)
Figure 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2019
Figure 31. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 34. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 35. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 40. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 41. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 44. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 45. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 56. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 57. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2019
Figure 60. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2019
Figure 61. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 84. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 85. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 88. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 89. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 96. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 97. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2019
Figure 101. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2019
Figure 108. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2019
Figure 109. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Janssen Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Bristol Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Kotobuki Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 117. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 119. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 121. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 123. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 125. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
